Erratum: Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. New perspectives in cancer immunotherapy: targeting IL-6 cytokine family.Journal for immunotherapy of cancer · 2023
   Review
2. Osteocytes and Bone Metastasis.Frontiers in endocrinology · 2020
   Review
3. Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.Frontiers in immunology · 2020
   Review
4. Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy.Current osteoporosis reports · 2018
   Review
5. Emerging and Established Models of Bone Metastasis.Cancers · 2018
   Review

Corrections and comments

• Erratum for
  Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.2016

Authors and funding

11 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract